Skip to main content

Is Activase the same as tPA?

Medically reviewed by Carmen Pope, BPharm. Last updated on March 4, 2025.

Official answer

by Drugs.com

Yes, Activase is the same as tPA but technically tPA is an abbreviation for tissue plasminogen activator which is the drug class that encompasses all tissue plasminogen activators of which there are 3 that have been FDA approved in the United States, namely:

Sometimes healthcare professionals use "tPA" to refer to Activase because it was the first tissue plasminogen activator that was approved. But this may cause confusion and has been the reason behind dozens of medication errors.

The main issue is that Activase is indicated for managing acute myocardial infarction, acute ischemic stroke, and acute massive pulmonary embolism. Historically, the other tissue plasminogen activators —Retavase and TNKase—were indicated ONLY for managing acute myocardial infarction. However, it's important to note that in February 2025, the FDA approved TNKase (tenecteplase) for the treatment of acute ischemic stroke. Despite this new approval, TNKase is still not FDA-approved for pulmonary embolism, and Retavase remains approved only for acute myocardial infarction.

Errors often arise because of confusion between the abbreviation TNK and tPA, which has resulted in TNKase being given to stroke patients instead of the intended Activase. While TNKase is now approved for stroke treatment, dosing and administration protocols differ between the medications.

Because all three drugs—Activase, TNKase, and Retavase—are tissue plasminogen activators, referring to any one of these products as "tPA" may lead to confusion about the intended product. To avoid confusion, do not use the abbreviation tPA, instead write down exactly the name of the drug intended.

Related questions

References
  • Ro M, Taylor MA, Jones R. Alteplase- and Tenecteplase-Related Errors and Risk Mitigation Strategies in the Treatment of Acute Ischemic Stroke: A Study of Event Reports From 52 Hospitals. Patient Safety. 2024;6(1). doi:10.33940/​001c.117322
  • Cohen MR, Smetzer JL. Avoid Using the Error-Prone Abbreviation "TPA"; Unexpected Painful Breath; Mix-ups among "V" Drugs; Brintellix-Brilinta: Name Change Needed. Hosp Pharm. 2016 Jan;51(1):11-14. doi: 10.1310/hpj5101-11. Epub 2016 Jan 1. PMID: 38745722; PMCID: PMC11089621.

Read next

Top 6 Eliquis Side Effects: What You Need to Know in Depth

Eliquis is an anticoagulant that is preferred over older anticoagulants, such as warfarin, because it doesn’t require regular blood tests, has fewer drug and food interactions, and it is less likely to cause bleeding. Although Eliquis is generally well tolerated, like any medication, it does have some side effects. We look in detail at six of the most common side effects of Eliquis:

  • Slight bleeding
  • Severe bleeding
  • Feeling sick (nausea)
  • Spinal blood clots
  • Increased liver enzymes and liver injury
  • Blood clots when stopping Eliquis.
Continue reading

Xarelto vs Eliquis: How do they compare?

Xarelto (rivaroxaban) and Eliquis (apixaban) are novel anticoagulants that make blood less likely to clot (also called thinning the blood). Both belong to the class of medicines known as factor Xa (FXa) inhibitors and they are two of the most popular blood thinners on the market. Either one may be used to reduce the risk of stroke or treat and prevent blood clots in conditions such as DVT. Continue reading

How do I stop and start Eliquis for surgery?

Follow your healthcare provider’s instructions on how to stop and restart Eliquis (apixaban) if you need to have surgery. In general, treatment with Eliquis should be paused at least 24-48 hours before surgery and may be restarted within 1-3 days after your procedure. This timeframe may be different if you have kidney problems. Continue reading

Related medical questions

Drug information

Related support groups